A5005608888- Respiratory viral infections research
- Pharmaceutical Practices and Patient Outcomes
- Urticaria and Related Conditions
- SARS-CoV-2 detection and testing
- Diabetes Management and Research
- Influenza Virus Research Studies
- Diabetes Treatment and Management
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Alcohol Consumption and Health Effects
- Pharmacy and Medical Practices
- Innovations in Medical Education
- Opioid Use Disorder Treatment
- Antiplatelet Therapy and Cardiovascular Diseases
- Pancreatic function and diabetes
- Pain Management and Opioid Use
- Inhalation and Respiratory Drug Delivery
- Nasal Surgery and Airway Studies
- Pharmacology and Obesity Treatment
- Medication Adherence and Compliance
- Clinical Laboratory Practices and Quality Control
- Health Literacy and Information Accessibility
- Antibiotic Use and Resistance
- Electroconvulsive Therapy Studies
- Poisoning and overdose treatments
Ferris State University
2008-2025
Marquette General Hospital
2022
Objective To summarize the current literature for Food and Drug Administration (FDA)-approved monoclonal antibodies used as add-on maintenance therapy in uncontrolled eosinophilic asthma. Data Sources PubMed was searched on December 17, 2018 using keywords: asthma, omalizumab, reslizumab, mepolizumab, benralizumab, dupilumab. Study Selection Studies evaluating safety efficacy of treatment severe or asthma were included. Results Twenty-one randomized, double-blind, placebo-controlled trials...
Abstract Community pharmacists' roles have expanded in recent years to include offering test and treat programs where they perform testing on Clinical Laboratory Improvement Amendment (CLIA)‐waived point‐of‐care (POCT) devices diagnose specific acute infectious conditions, such as influenza group A streptococcus (GAS) pharyngitis, then potentially prescribe dispense appropriate antimicrobials. Availability of these services pharmacies has several benefits, including increased access care,...
Introduction Clinical Laboratory Improvement Amendments (CLIA)-waived point-of-care tests (POCTs) have been available since the late 1980s, but their use in community pharmacy has expanded over last several years. Barriers exist for community-pharmacy-based CLIA-waived POC testing, including workflow, pharmacist scope of practice, and reimbursement. As pharmacies work to reduce these barriers, number participating POCT programs dramatically increased. There are lateral flow nucleic acid...
The authors report a case of syndrome inappropriate antidiuretic hormone (SIADH) associated with the use escitalopram in an elderly female patient. A 97-year-old white was admitted to hospital for suspected vertebral fracture and hyponatremia. Her serum sodium concentration 113 mEq/L (113 mmol/L) at admission. She started on 5 mg daily 1 week prior admission anxiety. During admission, her laboratory tests revealed hyponatremia hypo-osmolality urine hyperosmolality hypernatremia. stopped, she...